Express Scripts Holding Co (NASDAQ:ESRX) – Research analysts at Leerink Swann decreased their FY2019 earnings per share (EPS) estimates for Express Scripts in a note issued to investors on Thursday, September 20th. Leerink Swann analyst D. Larsen now expects that the company will earn $9.50 per share for the year, down from their prior estimate of $9.80.

Express Scripts (NASDAQ:ESRX) last posted its quarterly earnings results on Wednesday, August 1st. The company reported $2.22 EPS for the quarter, topping the Zacks’ consensus estimate of $2.20 by $0.02. Express Scripts had a return on equity of 25.49% and a net margin of 4.65%. The firm had revenue of $25.64 billion during the quarter, compared to analyst estimates of $25.43 billion. During the same period last year, the company earned $1.73 earnings per share. The business’s revenue for the quarter was up 1.2% on a year-over-year basis.

A number of other research firms have also commented on ESRX. BidaskClub lowered Express Scripts from a “buy” rating to a “hold” rating in a report on Tuesday, July 10th. Credit Suisse Group lowered Express Scripts from an “outperform” rating to a “neutral” rating and raised their price target for the stock from $90.00 to $96.50 in a report on Tuesday, September 18th. Zacks Investment Research raised Express Scripts from a “strong sell” rating to a “hold” rating in a report on Tuesday, June 26th. Royal Bank of Canada raised their price target on Express Scripts to $94.00 and gave the stock an “outperform” rating in a report on Monday, August 27th. Finally, William Blair raised Express Scripts from a “market perform” rating to an “outperform” rating in a research note on Wednesday, August 1st. Three investment analysts have rated the stock with a sell rating, twelve have issued a hold rating and six have given a buy rating to the stock. Express Scripts currently has a consensus rating of “Hold” and an average target price of $86.36.

Express Scripts stock opened at $94.08 on Monday. Express Scripts has a one year low of $55.80 and a one year high of $96.45. The company has a debt-to-equity ratio of 0.69, a current ratio of 0.71 and a quick ratio of 0.59. The firm has a market capitalization of $53.17 billion, a PE ratio of 13.25, a P/E/G ratio of 1.19 and a beta of 0.99.

In related news, insider Christine Houston sold 12,898 shares of Express Scripts stock in a transaction on Friday, August 10th. The stock was sold at an average price of $85.00, for a total transaction of $1,096,330.00. Following the completion of the sale, the insider now owns 110,908 shares of the company’s stock, valued at $9,427,180. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. 0.79% of the stock is currently owned by company insiders.

A number of large investors have recently bought and sold shares of the stock. Sumitomo Life Insurance Co. raised its position in Express Scripts by 4.5% during the second quarter. Sumitomo Life Insurance Co. now owns 15,313 shares of the company’s stock valued at $1,182,000 after purchasing an additional 657 shares in the last quarter. Gibraltar Capital Management Inc. increased its holdings in shares of Express Scripts by 1.1% in the second quarter. Gibraltar Capital Management Inc. now owns 68,278 shares of the company’s stock worth $5,272,000 after buying an additional 750 shares during the period. Pitcairn Co. increased its holdings in shares of Express Scripts by 6.0% in the first quarter. Pitcairn Co. now owns 13,465 shares of the company’s stock worth $930,000 after buying an additional 761 shares during the period. Hancock Holding Co. increased its holdings in shares of Express Scripts by 3.4% in the first quarter. Hancock Holding Co. now owns 23,052 shares of the company’s stock worth $1,592,000 after buying an additional 764 shares during the period. Finally, Pinnacle Financial Partners Inc. increased its holdings in shares of Express Scripts by 9.9% in the second quarter. Pinnacle Financial Partners Inc. now owns 8,600 shares of the company’s stock worth $663,000 after buying an additional 773 shares during the period. 84.69% of the stock is owned by institutional investors.

About Express Scripts

Express Scripts Holding Company operates as a pharmacy benefit management (PBM) company in the United States and Canada. The company's PBM segment offers clinical solutions; and specialized pharmacy care, home delivery and specialty pharmacy, retail network pharmacy administration, benefit design consultation, drug utilization review, drug formulary management, public exchange, administration of group purchasing organization, and digital consumer health and drug information services.

Featured Article: How to use beta for portfolio diversification

Earnings History and Estimates for Express Scripts (NASDAQ:ESRX)

Receive News & Ratings for Express Scripts Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Express Scripts and related companies with MarketBeat.com's FREE daily email newsletter.